Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of an Individualized Transfusion Strategy to a Conventional Strategy in Patients Undergoing Peripheral Veno-arterial ECMO for Refractory Cardiogenic Shock: a Randomized Controlled Trial - ICONE

NCT05699005 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT05699005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05699005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of an Individualized Transfusion Strategy to a Conventional Strategy in Patients Undergoing Peripheral Veno-arterial ECMO for Refractory Cardiogenic Shock: a Randomized Controlled Trial - ICONE
Lead sponsor
University Hospital, Lille
Phase
Phase 1
Overall status
Recruiting
Start date
September 18, 2023
Completion date
December 18, 2028
Enrollment
236 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, cardiogenic shock, extracorporeal membrane oxygenation, oxygen delivery, transfusion related complication